Señales en vivo de STRO | Maximiza tus Ganancias con Getagraph.com

COMPRAR 114836 min ago

@ $4.45

Emitido: 14 feb 2024 @ 13:11

Retorno: -13.95%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: -4.28 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	610 891
Volumen promedio	986 832
Capitalización de mercado	294.61M
EPS	$0 ( 2024-04-04 )
Próxima fecha de ganancias	( $-0.910 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.15
ATR14	$0.00500 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Srinivasan Venkatesh	Buy	2 500	Common Stock
2024-05-01	Srinivasan Venkatesh	Sell	892	Common Stock
2024-05-01	Srinivasan Venkatesh	Sell	2 500	Restricted Stock Unit (RSU)
2024-04-11	Srinivasan Venkatesh	Sell	21 250	Restricted Stock Unit (RSU)
2024-04-11	Srinivasan Venkatesh	Buy	21 250	Common Stock

INSIDER POWER
67.42
Last 99 transactions
Buy: 2 156 384 \| Sell: 407 712

Volumen Correlación

Largo: 0.16 (neutral)

Corto: -0.83 (strong negative)

Signal:(44.133) Neutral

Sutro Biopharma Inc Correlación

10 Correlaciones Más Positivas
TNGX	0.88
CARA	0.864
EYE	0.821
SLM	0.809
ACHC	0.801
LSXMK	0.801

10 Correlaciones Más Negativas
ALR	-0.839
INZY	-0.833
BTBD	-0.83
INOD	-0.828
GETVV	-0.826
HYPR	-0.824
FTIV	-0.812
OCUL	-0.803
SELF	-0.802

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sutro Biopharma Inc Correlación - Moneda/Commodity

0.13
( neutral )

0.19
( neutral )

0.00
( neutral )

-0.17
( neutral )

-0.01
( neutral )

Sutro Biopharma Inc Finanzas

Annual	2023
Ingresos:	$153.73M
Beneficio Bruto:	$146.92M (95.57 %)
EPS:	$-1.780

FY	2023
Ingresos:	$153.73M
Beneficio Bruto:	$146.92M (95.57 %)
EPS:	$-1.780

FY	2022
Ingresos:	$67.77M
Beneficio Bruto:	$59.48M (87.77 %)
EPS:	$-2.35

FY	2021
Ingresos:	$61.88M
Beneficio Bruto:	$61.88M (100.00 %)
EPS:	$-2.29

Financial Reports:

No articles found.

Sutro Biopharma Inc

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.